bluebird bio, Inc. (0HOH.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 06:47PM BST
| Previous close | 1.0650 |
| Open | 1.1397 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 1.0700 - 1.1397 |
| 52-week range | 0.8856 - 5.5280 |
| Volume | |
| Avg. volume | 57,271 |
| Market cap | 610,789 |
| Beta (5Y monthly) | 0.87 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
bluebird bio Inc (BLUE) Q1 2024 Earnings: Surpasses Revenue Expectations with Strategic Focus ...
Detailed Analysis of Financial Performance and Future Outlook
- Zacks
bluebird (BLUE) Tops on Q1 Sales, Zynteglo Progresses Well
bluebird (BLUE) beats sales estimates in the first quarter on increased Zynteglo product revenues. The company is on track with the ongoing launch of its gene therapies.
- Insider Monkey
bluebird bio, Inc. (NASDAQ:BLUE) Q4 2023 Earnings Call Transcript
bluebird bio, Inc. (NASDAQ:BLUE) Q4 2023 Earnings Call Transcript March 26, 2024 bluebird bio, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to bluebird bio Fourth Quarter and 2023 Annual Results Conference Call. At this […]
© 2024 Yahoo. All rights reserved.